Anthony Fauci says Pfizer vaccine's trial success may boost acceptance


WASHINGTON: The success of Pfizer Inc’s Covid-19 vaccine trial may help persuade more people to get inoculated amid a surge in new coronavirus cases, according to Anthony Fauci, the top US infectious-disease doctor.

Pfizer’s vaccine, developed in collaboration with Germany’s BioNTech SE, has “an extraordinarily high degree of efficacy — more than 90%, close to 95%,” Fauci said in an interview.

That could be a key factor in overcoming reluctance to take pandemic vaccines that have been developed at top speed.

“What I would hope is that even though there’s a degree of skepticism about vaccines in general, that when the general public sees how effective this vaccine is,” said Fauci, director of the National Institute of Allergy and Infectious Diseases, “we might see a turnaround of the attitude toward vaccination.”

The US may begin offering the vaccine to priority groups at the end of December, Fauci said.





READ SOURCE

READ  Wheat procurement hits all-time high

LEAVE A REPLY

Please enter your comment!
Please enter your name here